A detailed history of Wolverine Trading, LLC transactions in Relmada Therapeutics, Inc. stock. As of the latest transaction made, Wolverine Trading, LLC holds 24,200 shares of RLMD stock, worth $6,534. This represents 0.0% of its overall portfolio holdings.

Number of Shares
24,200
Previous 21,100 14.69%
Holding current value
$6,534
Previous $68,000 82.35%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$3.1 - $6.8 $2,563 - $5,623
827 Added 7.74%
11,511 $53,000
Q4 2023

Feb 14, 2024

BUY
$2.45 - $4.22 $26,175 - $45,086
10,684 New
10,684 $44,000

Others Institutions Holding RLMD

About RELMADA THERAPEUTICS, INC.


  • Ticker RLMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,608,500
  • Market Cap $7.72M
  • Description
  • Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a new chemical entity and N-methyl-D-aspartate receptor antagonist that ...
More about RLMD
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.